XML 54 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Long-Term Investments (Details) - Schedule of Balance Sheet - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
BioFirst [Member]    
Condensed Balance Sheet Statements, Captions [Line Items]    
Current Assets $ 1,690,060 $ 1,543,152
Non-current Assets 651,221 739,472
Current Liabilities 2,236,708 2,663,051
Non-current Liabilities 366,634 103,447
Stockholders’ Equity (Deficit) (262,061) (483,874)
Rgene [Member]    
Condensed Balance Sheet Statements, Captions [Line Items]    
Current Assets 56,091 68,302
Non-current Assets 239,594 303,893
Current Liabilities 2,407,204 2,478,868
Non-current Liabilities 1,465 2,441
Stockholders’ Equity (Deficit) $ (2,112,984) $ (2,109,114)